Mangatol, Junard N.
HRN: 10-36-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2023
MUPIROCIN 2%, 15G (TUBE)
04/16/2023
04/22/2023
TOPICAL
NA
BID
Abrasions
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes